AKT Inhibitor in Oestrogen Positive Breast Cancer

NCT02077569 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Nottingham

Collaborators